BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15139119)

  • 1. [The bioactivity of angiotensin II and the effects of related Chinese Herbs].
    Shen YH; Chen CX
    Zhongguo Zhong Yao Za Zhi; 2003 May; 28(5):394-7, 431. PubMed ID: 15139119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The research of estrogen receptor modulator and correlative Chinese herbs].
    He HL; Jin H; Wang JF; Niu JZ
    Zhongguo Zhong Yao Za Zhi; 2002 Nov; 27(11):805-7. PubMed ID: 12776580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics.
    Prosser HC; Forster ME; Richards AM; Pemberton CJ
    Cardiovasc Res; 2009 Apr; 82(1):40-50. PubMed ID: 19147651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.
    du Toit EF; Nabben M; Lochner A
    Basic Res Cardiol; 2005 Jul; 100(4):346-54. PubMed ID: 15821998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular matrix and cardiovascular diseases.
    Ju H; Dixon IM
    Can J Cardiol; 1996 Dec; 12(12):1259-67. PubMed ID: 8987966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of sapindoside on blood pressure and vasoactive substance in renovascular hypertension rat].
    Wang WS; Long ZJ; Zhang L; Bian H; Wang L; Chen M
    Zhongguo Zhong Yao Za Zhi; 2007 Aug; 32(16):1703-5. PubMed ID: 18027673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin-angiotensin inhibition reverses advanced cardiac remodeling in aging spontaneously hypertensive rats.
    Ito N; Ohishi M; Yamamoto K; Tatara Y; Shiota A; Hayashi N; Komai N; Yanagitani Y; Rakugi H; Ogihara T
    Am J Hypertens; 2007 Jul; 20(7):792-9. PubMed ID: 17586415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
    Garg S; Narula J; Marelli C; Cesario D
    Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II type 2 receptor gene transfer elicits cardioprotective effects in an angiotensin II infusion rat model of hypertension.
    Falcón BL; Stewart JM; Bourassa E; Katovich MJ; Walter G; Speth RC; Sumners C; Raizada MK
    Physiol Genomics; 2004 Nov; 19(3):255-61. PubMed ID: 15383639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of Peritrophe roxburghiana on blood pressure in renal hypertensive and hyperlipidemic rats].
    Cheng Z; Lü J; Liu J
    Zhong Yao Cai; 2004 Dec; 27(12):927-30. PubMed ID: 15807245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components.
    Kurdi M; De Mello WC; Booz GW
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1357-67. PubMed ID: 15833268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of Huoxue Qianyang granules in revising the left ventricular hypertrophy of spontaneous hypertension rats].
    Zhou D; Xiao MF; Hu R
    Zhong Xi Yi Jie He Xue Bao; 2006 Nov; 4(6):606-10. PubMed ID: 17090377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influnce of Tinglizi on some neuroendocrine factors and type I and III collagen in ventricular remodeling induced by abdominal aortic banding in rats].
    Guo J; Chen CX
    Zhong Yao Cai; 2007 Aug; 30(8):963-7. PubMed ID: 18074846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 17. [The influence on hemodynamics of myocardial ischemic dogs and blood pressure of animals with shenfu injection].
    Yang FJ; Wang ZR; Lin DP; Qu Y; Yin HH; Shi LL; Guo HL; Xiao J; Wang YQ; Liu RT
    Zhongguo Zhong Yao Za Zhi; 2003 Mar; 28(3):259-62. PubMed ID: 15015316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Protective effects of San Baoxin on injury induced by myocardical ischemic reperfusion and anti-thrombosis in rats].
    Gao HL; Wang YY; Li YK; Ning KY; Li LD
    Zhongguo Zhong Yao Za Zhi; 2005 Jun; 30(11):844-6. PubMed ID: 16110868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective effect of ASS on myocardial ischemia-reperfusion injury in rats].
    Sui DY; Qu SC; Yu XF; Chen YP; Ma XY
    Zhongguo Zhong Yao Za Zhi; 2004 Jan; 29(1):71-4. PubMed ID: 15709388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.